| 2026-05-22 |
详情>>
内部人交易：
Gibson Christopher共交易2笔
|
| 2026-05-06 |
详情>>
股本变动：
变动后总股本52990.52万股
|
| 2026-05-06 |
详情>>
业绩披露：
2026年一季报每股收益-0.22美元,归母净利润-1.18亿美元,同比去年增长41.97%
|
| 2026-05-06 |
财报披露：
美东时间 2026-05-06 盘前发布财报
|
| 2026-04-30 |
股东大会：
将于2026-06-17召开股东大会
会议内容 ▼▲
- 1.Two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earliest death, resignation or removal
2.To approve the compensation of our Named Executive Officers, as disclosed in the proxy statement accompanying this notice;
3.The appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026
4.Any other business properly brought before the Annual Meeting or any continuation, adjournments, or postponements thereof.
|
| 2026-02-25 |
详情>>
业绩披露：
2023年年报每股收益-1.58美元,归母净利润-3.28亿美元,同比去年增长-36.99%
|
| 2026-02-25 |
详情>>
业绩披露：
2025年年报每股收益-1.44美元,归母净利润-6.45亿美元,同比去年增长-39.06%
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.27美元,归母净利润-5.37亿美元,同比去年增长-88.46%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益-0.91美元,归母净利润-3.74亿美元,同比去年增长-98.18%
|
| 2025-05-05 |
详情>>
业绩披露：
2025年一季报每股收益-0.5美元,归母净利润-2.02亿美元,同比去年增长-121.6%
|
| 2025-04-28 |
股东大会：
将于2025-06-18召开股东大会
会议内容 ▼▲
- 1.To elect three Class I Directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
|
| 2025-02-28 |
详情>>
业绩披露：
2022年年报每股收益-1.36美元,归母净利润-2.39亿美元,同比去年增长-28.42%
|
| 2025-02-28 |
详情>>
业绩披露：
2024年年报每股收益-1.69美元,归母净利润-4.64亿美元,同比去年增长-41.33%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.12美元,归母净利润-2.85亿美元,同比去年增长-21.14%
|
| 2024-10-10 |
股东大会：
将于2024-11-12召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of shares of Class A Common Stock of Recursion in connection with Recursion’s acquisition of the entire issued and to be issued share capital of Exscientia plc pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, for purposes of complying with the applicable provisions of the Nasdaq Listing Rules (the “Recursion Share Issuance Proposal”);
2.To approve any motion to adjourn the Recursion Special Meeting to another time or place, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Recursion Special Meeting to approve the Recursion Share Issuance Proposal (the “Recursion Adjournment Proposal”).
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.79美元,归母净利润-1.89亿美元,同比去年增长-32.99%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.39美元,归母净利润-9137.3万美元,同比去年增长-39.87%
|
| 2024-04-23 |
股东大会：
将于2024-06-03召开股东大会
会议内容 ▼▲
- 1.To elect three Class III Directors to our Board of Directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.
2.To approve, on an advisory basis, the compensation of our named executive officers.
|
| 2023-04-28 |
股东大会：
将于2023-06-16召开股东大会
会议内容 ▼▲
- 1.To elect two Class II Directors to our Board of Directors, to serve until the 2026 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To hold an advisory vote on the frequency of the advisory vote to approve executive compensation;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
|
| 2022-04-28 |
股东大会：
将于2022-06-14召开股东大会
会议内容 ▼▲
- 1.TO ELECT three Class I directors to our Board of Directors, to serve until the 2025 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earliest death, resignation or removal
2.TO RATIFY the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022
3.TO TRANSACT any other business properly brought before the Annual Meeting or any continuation, adjournments, or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|